5AM Venture Management
Latest statistics and disclosures from 5AM Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MPLT, TYRA, TRDA, PHVS, CAMP, and represent 52.11% of 5AM Venture Management's stock portfolio.
- Reduced shares in these 5 stocks: ERAS (-$56M), Centessa Pharmaceuticals (-$23M), GHRS (-$8.1M), SRZN, RLYB.
- Sold out of its positions in Centessa Pharmaceuticals, ERAS, RLYB, GHRS.
- 5AM Venture Management was a net seller of stock by $-93M.
- 5AM Venture Management has $288M in assets under management (AUM), dropping by -20.08%.
- Central Index Key (CIK): 0001799883
Tip: Access up to 7 years of quarterly data
Positions held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for 5AM Venture Management
5AM Venture Management holds 16 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Maplight Therapeutics (MPLT) | 11.8 | $34M | 950k | 35.84 |
|
|
| Tyra Biosciences (TYRA) | 11.4 | $33M | 1.0M | 31.94 |
|
|
| Entrada Therapeutics (TRDA) | 10.4 | $30M | 4.1M | 7.36 |
|
|
| Pharvaris N V (PHVS) | 9.6 | $28M | 798k | 34.58 |
|
|
| Camp4 Therapeutics Corp (CAMP) | 8.9 | $26M | 5.9M | 4.37 |
|
|
| Artiva Biotherapeutics (ARTV) | 7.9 | $23M | 2.4M | 9.70 |
|
|
| Tectonic Therapeutic (TECX) | 7.2 | $21M | 607k | 34.38 |
|
|
| Zentalis Pharmaceuticals (ZNTL) | 6.7 | $19M | 3.9M | 4.85 |
|
|
| Celldex Therapeutics Com New (CLDX) | 6.4 | $19M | 497k | 37.21 |
|
|
| Eyepoint Com New (EYPT) | 5.2 | $15M | 1.1M | 14.30 |
|
|
| Biohaven (BHVN) | 3.8 | $11M | 739k | 14.88 |
|
|
| Surrozen Com New (SRZN) | 2.4 | $7.0M | -30% | 271k | 25.95 |
|
| Skye Bioscience Com New (SKYE) | 2.3 | $6.7M | 9.7M | 0.69 |
|
|
| Alx Oncology Hldgs (ALXO) | 2.2 | $6.3M | 3.1M | 2.07 |
|
|
| Protara Therapeutics Com Stk (TARA) | 1.8 | $5.2M | 1.4M | 3.82 |
|
|
| Silence Therapeutics Ads (SLN) | 1.8 | $5.2M | 476k | 10.98 |
|
Past Filings by 5AM Venture Management
SEC 13F filings are viewable for 5AM Venture Management going back to 2019
- 5AM Venture Management 2026 Q2 filed Aug. 14, 2026
- 5AM Venture Management 2026 Q1 filed May 15, 2026
- 5AM Venture Management 2025 Q4 filed Feb. 17, 2026
- 5AM Venture Management 2025 Q3 filed Nov. 14, 2025
- 5AM Venture Management 2025 Q2 filed Aug. 14, 2025
- 5AM Venture Management 2025 Q1 filed May 15, 2025
- 5AM Venture Management 2024 Q4 filed Feb. 14, 2025
- 5AM Venture Management 2024 Q3 filed Nov. 14, 2024
- 5AM Venture Management 2024 Q2 filed Aug. 14, 2024
- 5AM Venture Management 2024 Q1 filed May 15, 2024
- 5AM Venture Management 2023 Q4 filed Feb. 14, 2024
- 5AM Venture Management 2023 Q3 filed Nov. 14, 2023
- 5AM Venture Management 2023 Q2 filed Aug. 14, 2023
- 5AM Venture Management 2023 Q1 filed May 15, 2023
- 5AM Venture Management 2022 Q4 filed Feb. 14, 2023
- 5AM Venture Management 2022 Q3 filed Nov. 14, 2022